Effects of the transient receptor potential vanilloid 1 antagonist A-425619 on body temperature and thermoregulation in the rat

Neuroscience

Volumn 156, Issue 1, 2008, Pages 165-174

  Mills, C ^a   McMackin, M ^a   Jaffe, R ^a   Yu, J ^a   Zininberg, E ^a   Slee, D ^a   Gogas, K ^a   Bradbury, M ^a  

^a NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

capsaicin; hyperthermia; inflammation

Indexed keywords

1 ISOQUINOLIN 5 YL 3 (4 TRIFLUOROMETHYL BENZYL) UREA; A 425619; CAPSAICIN; DRUG RECEPTOR; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 1 BLOCKING AGENT;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; HYPOTHERMIA; INFLAMMATION; LOCOMOTION; MALE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; THERMOREGULATION;

ADMINISTRATION, ORAL; ANIMALS; BODY TEMPERATURE; BODY TEMPERATURE REGULATION; CAPSAICIN; CIRCADIAN RHYTHM; DRUG ADMINISTRATION SCHEDULE; FEVER; HYPOTHALAMUS; HYPOTHERMIA; ISOQUINOLINES; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRPV CATION CHANNELS; UREA;

EID: 51249117321     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.06.069     Document Type: Article

References (47)

1. Acs G., Palkovits M., and Blumberg P.M. Specific binding of [3H]resiniferatoxin by human and rat preoptic area, locus ceruleus, medial hypothalamus, reticular formation and ventral thalamus membrane preparations. Life Sci 59 (1996) 1899-1908
2. Boulant J.A. Hypothalamic neurons. Mechanisms of sensitivity to temperature. Ann N Y Acad Sci 856 (1998) 108-115
3. Caterina M.J. Transient receptor potential ion channels as participants in thermosensation and thermoregulation. Am J Physiol Regul Integr Comp Physiol 292 (2007) R64-R76
4. Caterina M.J., Leffler A., Malmberg A.B., Martin W.J., Trafton J., Petersen-Zeitz K.R., Koltzenburg M., Basbaum A.I., and Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288 (2000) 306-313
5. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., and Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389 (1997) 816-824
6. Cui M., Honore P., Zhong C., Gauvin D., Mikusa J., Hernandez G., Chandran P., Gomtsyan A., Brown B., Bayburt E.K., Marsh K., Bianchi B., McDonald H., Niforatos W., Neelands T.R., Moreland R.B., Decker M.W., Lee C.H., Sullivan J.P., and Faltynek C.R. TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists. J Neurosci 26 (2006) 9385-9393
7. Dinis P., Charrua A., Avelino A., Yaqoob M., Bevan S., Nagy I., and Cruz F. Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis. J Neurosci 24 (2004) 11253-11263
8. Dogan M.D., Patel S., Rudaya A.Y., Steiner A.A., Szekely M., and Romanovsky A.A. Lipopolysaccharide fever is initiated via a capsaicin-sensitive mechanism independent of the subtype-1 vanilloid receptor. Br J Pharmacol 143 (2004) 1023-1032
9. Drizin I., Gomtsyan A., Bayburt E.K., Schmidt R.G., Zheng G.Z., Perner R.J., DiDomenico S., Koenig J.R., Turner S.C., Jinkerson T.K., Brown B.S., Keddy R.G., McDonald H.A., Honore P., Wismer C.T., Marsh K.C., Wetter J.M., Polakowski J.S., Segreti J.A., Jarvis M.F., Faltynek C.R., and Lee C.H. Structure-activity studies of a novel series of 5,6-fused heteroaromatic ureas as TRPV1 antagonists. Bioorg Med Chem 14 (2006) 4740-4749
10. Fitzgerald M. Capsaicin and sensory neurones: a review. Pain 15 (1983) 109-130
11. Gavva N.R., Bannon A.W., Hovland Jr. D.N., Lehto S.G., Klionsky L., Surapaneni S., Immke D.C., Henley C., Arik L., Bak A., Davis J., Ernst N., Hever G., Kuang R., Shi L., Tamir R., Wang J., Wang W., Zajic G., Zhu D., Norman M.H., Louis J.C., Magal E., and Treanor J.J. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade. J Pharmacol Exp Ther 323 (2007) 128-137
12. Gavva N.R., Bannon A.W., Surapaneni S., Hovland Jr. D.N., Lehto S.G., Gore A., Juan T., Deng H., Han B., Klionsky L., Kuang R., Le A., Tamir R., Wang J., Youngblood B., Zhu D., Norman M.H., Magal E., Treanor J.J., and Louis J.C. The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation. J Neurosci 27 (2007) 3366-3374
13. Gavva N.R., Tamir R., Qu Y., Klionsky L., Zhang T.J., Immke D., Wang J., Zhu D., Vanderah T.W., Porreca F., Doherty E.M., Norman M.H., Wild K.D., Bannon A.W., Louis J.C., and Treanor J.J. AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. J Pharmacol Exp Ther 313 (2005) 474-484
14. Gavva N.R., Treanor J.J., Garami A., Fang L., Surapaneni S., Akrami A., Alvarez F., Bak A., Darling M., Gore A., Jang G.R., Kesslak J.P., Ni L., Norman M.H., Palluconi G., Rose M.J., Salfi M., Tan E., Romanovsky A.A., Banfield C., and Davar G. Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain 136 (2008) 202-210
15. Gomtsyan A., Bayburt E.K., Schmidt R.G., Zheng G.Z., Perner R.J., Didomenico S., Koenig J.R., Turner S., Jinkerson T., Drizin I., Hannick S.M., Macri B.S., McDonald H.A., Honore P., Wismer C.T., Marsh K.C., Wetter J., Stewart K.D., Oie T., Jarvis M.F., Surowy C.S., Faltynek C.R., and Lee C.H. Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties. J Med Chem 48 (2005) 744-752
16. Gordon C.J. Thermal biology of the laboratory rat. Physiol Behav 47 (1990) 963-991
17. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 43 (1991) 143-201
18. Honore P., Wismer C.T., Mikusa J., Zhu C.Z., Zhong C., Gauvin D.M., Gomtsyan A., El Kouhen R., Lee C.H., Marsh K., Sullivan J.P., Faltynek C.R., and Jarvis M.F. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats. J Pharmacol Exp Ther 314 (2005) 410-421
19. Hori T. Capsaicin and central control of thermoregulation. Pharmacol Ther 26 (1984) 389-416
20. Iida T., Shimizu I., Nealen M.L., Campbell A., and Caterina M. Attenuated fever response in mice lacking TRPV1. Neurosci Lett 378 (2005) 28-33 >
21. Immke D.C., and Gavva N.R. The TRPV1 receptor and nociception. Semin Cell Dev Biol 17 (2006) 582-591
22. Jancso-Gabor A., Szolcsanyi J., and Jancso N. Irreversible impairment of thermoregulation induced by capsaicin and similar pungent substances in rats and guinea-pigs. J Physiol 206 (1970) 495-507
23. Jancso-Gabor A., Szolcsanyi J., and Jancso N. Stimulation and desensitization of the hypothalamic heat-sensitive structures by capsaicin in rats. J Physiol 208 (1970) 449-459
24. Jancso G., Kiraly E., Joo F., Such G., and Nagy A. Selective degeneration by capsaicin of a subpopulation of primary sensory neurons in the adult rat. Neurosci Lett 59 (1985) 209-214
25. Karlsson U., Sundgren-Andersson A.K., Johansson S., and Krupp J.J. Capsaicin augments synaptic transmission in the rat medial preoptic nucleus. Brain Res 1043 (2005) 1-11
26. Khan I.M., Wennerholm M., Singletary E., Polston K., Zhang L., Deerinck T., Yaksh T.L., and Taylor P. Ablation of primary afferent terminals reduces nicotinic receptor expression and the nociceptive responses to nicotinic agonists in the spinal cord. J Neurocytol 33 (2004) 543-556
27. Kobayashi A., Osaka T., Namba Y., Inoue S., Lee T.H., and Kimura S. Capsaicin activates heat loss and heat production simultaneously and independently in rats. Am J Physiol 275 (1998) R92-R98
28. Lee T.H., Lee J.W., Osaka T., Kobayashi A., Namba Y., Inoue S., and Kimura S. Lack of integrative control of body temperature after capsaicin administration. Korean J Intern Med 15 (2000) 103-108
29. Levine J.D., and Alessandri-Haber N. TRP channels: targets for the relief of pain. Biochim Biophys Acta 1772 (2007) 989-1003
30. Moore R.Y., and Danchenko R.L. Paraventricular-subparaventricular hypothalamic lesions selectively affect circadian function. Chronobiol Int 19 (2002) 345-360
31. Moriyama T., Higashi T., Togashi K., Iida T., Segi E., Sugimoto Y., Tominaga T., Narumiya S., and Tominaga M. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol Pain 1 (2005) 3
32. Nagy I., Santha P., Jancso G., and Urban L. The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology. Eur J Pharmacol 500 (2004) 351-369
33. Numazaki M., and Tominaga M. Nociception and TRP channels. Curr Drug Targets CNS Neurol Disord 3 (2004) 479-485
34. Roberts L.A., Christie M.J., and Connor M. Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. Br J Pharmacol 137 (2002) 421-428
35. Russell L.C., and Burchiel K.J. Neurophysiological effects of capsaicin. Brain Res 320 (1984) 165-176
36. Seebacher F., and Murray S.A. Transient receptor potential ion channels control thermoregulatory behaviour in reptiles. PLoS ONE 2 (2007) e281
37. Smart D., Gunthorpe M.J., Jerman J.C., Nasir S., Gray J., Muir A.I., Chambers J.K., Randall A.D., and Davis J.B. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 129 (2000) 227-230
38. Smart D., and Jerman J.C. Anandamide: an endogenous activator of the vanilloid receptor. Trends Pharmacol Sci 21 (2000) 134
39. Steiner A.A., Turek V.F., Almeida M.C., Burmeister J.J., Oliveira D.L., Roberts J.L., Bannon A.W., Norman M.H., Louis J.C., Treanor J.J., Gavva N.R., and Romanovsky A.A. Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors. J Neurosci 27 (2007) 7459-7468
40. Swanson D.M., Dubin A.E., Shah C., Nasser N., Chang L., Dax S.L., Jetter M., Breitenbucher J.G., Liu C., Mazur C., Lord B., Gonzales L., Hoey K., Rizzolio M., Bogenstaetter M., Codd E.E., Lee D.H., Zhang S.P., Chaplan S.R., and Carruthers N.I. Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist. J Med Chem 48 (2005) 1857-1872
41. Szabo T., Biro T., Gonzalez A.F., Palkovits M., and Blumberg P.M. Pharmacological characterization of vanilloid receptor located in the brain. Brain Res Mol Brain Res 98 (2002) 51-57
42. Szallasi A., Cortright D.N., Blum C.A., and Eid S.R. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov 6 (2007) 357-372
43. Szelenyi Z., Hummel Z., Szolcsanyi J., and Davis J.B. Daily body temperature rhythm and heat tolerance in TRPV1 knockout and capsaicin pretreated mice. Eur J Neurosci 19 (2004) 1421-1424
44. Szikszay M., Obal Jr. F., and Obal F. Dose-response relationships in the thermoregulatory effects of capsaicin. Naunyn Schmiedebergs Arch Pharmacol 320 (1982) 97-100
45. Tamayo N., Liao H., Stec M.M., Wang X., Chakrabarti P., Retz Z., Doherty E.M., Surapaneni S., Tamir R., Bannon A.W., Gavva N.R., and Norman M.H. Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists. J Med Chem 51 (2008) 2744-2757
46. 2+ influx via TRPV1 channels. EMBO J 24 (2005) 3026-3037
47. Whyte D.G., and Johnson A.K. Thermoregulatory role of periventricular tissue surrounding the anteroventral third ventricle (AV3V) during acute heat stress in the rat. Clin Exp Pharmacol Physiol 32 (2005) 457-461